Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
6.32
+0.13 (2.10%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $814.08 million as of December 20, 2024. Its market cap has decreased by -21.60% in one year.
Market Cap
814.08M
Enterprise Value
550.82M
1-Year Change
-21.60%
Ranking
Category
Stock Price
$6.32
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $814.08M, a decrease of -63.99%. That is a compound annual growth rate of -25.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 814.08M | -34.15% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 89bio | 826.60M |
| Immatics | 821.17M |
| Paragon 28 | 820.46M |
| Pliant Therapeutics | 809.35M |
| AbCellera Biologics | 800.44M |
| Avid Bioservices | 788.67M |
| agilon health | 774.59M |
| Tyra Biosciences | 766.64M |